139 related articles for article (PubMed ID: 7238044)
21. The use of a contraceptive vaginal ring governed by the pattern of individual uterine bleeding.
Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1979 Apr; 19(4):401-9. PubMed ID: 455988
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration.
Stanczyk FZ; Hiroi M; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Contraception; 1975 Sep; 12(3):279-98. PubMed ID: 1164847
[TBL] [Abstract][Full Text] [Related]
23. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
24. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
Granger LR; Roy S; Mishell DR
Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
[TBL] [Abstract][Full Text] [Related]
25. Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol.
Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1979 Jul; 20(1):11-8. PubMed ID: 477313
[TBL] [Abstract][Full Text] [Related]
26. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
Nilsson O; Englund D; Weiner E; Victor A
Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
[TBL] [Abstract][Full Text] [Related]
27. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Landgren BM; Diczfalusy E
Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
[TBL] [Abstract][Full Text] [Related]
28. Initial clinical studies of intravaginal rings containing norethindrone and norgestrel.
Mishell DR; lumkin M; Jackanicz T
Contraception; 1975 Sep; 12(3):253-60. PubMed ID: 1164845
[TBL] [Abstract][Full Text] [Related]
29. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
[TBL] [Abstract][Full Text] [Related]
31. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
[TBL] [Abstract][Full Text] [Related]
32. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
Souka AR; el Sokkary H; Kamel M; Hassan M
Contraception; 1986 Apr; 33(4):365-71. PubMed ID: 3731776
[TBL] [Abstract][Full Text] [Related]
33. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Belsey EM
Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505
[TBL] [Abstract][Full Text] [Related]
34. The vaginal contraceptive pill.
Coutinho E
IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
[TBL] [Abstract][Full Text] [Related]
35. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.
Mishell DR; Lumkin ME
Fertil Steril; 1970 Feb; 21(2):99-103. PubMed ID: 5414562
[TBL] [Abstract][Full Text] [Related]
36. Vaginal rings for contraception: endocrine parameters.
Olsson SE
Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
[TBL] [Abstract][Full Text] [Related]
37. Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol.
Olsson SE; Odlind V
Contraception; 1990 Nov; 42(5):563-72. PubMed ID: 2272184
[TBL] [Abstract][Full Text] [Related]
38. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
Russowsky M; Sartoretto JN
Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
[TBL] [Abstract][Full Text] [Related]
39. [Vaginal ring contraception in hypertensive women].
Basdevant A; Elkik F; Guy-grand B; Conard J; Corvol P
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):365-7. PubMed ID: 12280208
[TBL] [Abstract][Full Text] [Related]
40. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
